- Report
- January 2025
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- February 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
The Reproductive Hormone market is a subset of the Sexual and Reproductive Health Drugs market. It includes drugs used to treat infertility, menopause, and other reproductive health issues. These drugs are used to regulate hormones, such as estrogen and progesterone, which are essential for reproductive health. They can also be used to treat conditions such as endometriosis, polycystic ovary syndrome, and premenstrual dysphoric disorder.
Reproductive Hormone drugs are available in both prescription and over-the-counter forms. They are typically administered orally, through injections, or through topical creams. Common side effects of these drugs include nausea, headaches, and breast tenderness.
Some companies in the Reproductive Hormone market include Merck, Pfizer, Bayer, and Novartis. Show Less Read more